Finance

Stifel Nicolaus Maintains a Buy Rating on Fulcrum Therapeutics (FULC)

Stifel Nicolaus analyst Dae Gon Ha maintained a Buy rating on Fulcrum Therapeutics (FULC – Research Report) on March 7 and set a price target of …

Read more

Show More

Related Articles

Back to top button